Page 138 - ILAE_Lectures_2015

70. PANAYIOTOPOULOS CP, FERRIE CD, KNOTT C et al. Interaction of lamotrigine with sodium valproate
[letter] [see comments]. Lancet 1993; 341:445.

71. ECHANIZ-LAGUNA A, THIRIAUX A, RUOLT-OLIVESI I et al. Lupus anticoagulant induced by the
combination of valproate and lamotrigine. Epilepsia 1999; 40:1661-1663.

72. MATTSON RH, CRAMER JA. Valproic acid and ethosuximide interaction. Ann Neurol 1980; 7:583-584
73. MIKKELSEN B, BIRKET-SMITH E, BRADT S et al. Clonazepam in the treatment of epilepsy. A controlled

clinical trial in simple absences, bilateral massive epileptic myoclonus, and atonic seizures. Arch Neurol 1976;
33:322-325.
74. OBEID T, PANAYIOTOPOULOS CP. Clonazepam in juvenile myoclonic epilepsy. Epilepsia 1989; 30:603-606
75. AMES FR, ENDERSTEIN O. Clinical and EEG response to clonazepam in four patients with self-induced
photosensitive epilepsy. S Afr Med J 1976; 50:1432-1434.
76. BROWNE TR. Clonazepam. N Engl J Med 1978; 299:812-816.
77. LOMBROSO CT, FORSYTHE I. Long term follow-up of acetazolamide (diamox) in the treatment of epilepsy.
Epilepsia 1969; 1:493-500.
78. RESOR SR Jr, RESOR LD. Chronic acetazolamide monotherapy in the treatment of juvenile myoclonic epilepsy
[see comments]. Neurology 1990; 40:1677-1681.
79. DI BONAVENTURA C, FATTOUCH J, MARI F et al. Clinical experience with levetiracetam in idiopathic
generalised epilepsy according to different syndrome subtypes. Epileptic Disord 2005; 7:231-235.
80. BERKOVIC SF, KNOWLTON RC, LEROY RF et al. Placebo-controlled study of levetiracetam in idiopathic
generalised epilepsy. Neurology 2007; 69:1752-1760.
81. SNEAD OC, HOSEY LC. Exacerbation of seizures in children by carbamazepine. New Engl J Med 1985;
313:916-921.
82. PARKER AP, AGATHONIKOU A, ROBINSON RO et al. Inappropriate use of carbamazepine and vigabatrin
in typical absence seizures. Dev Med Child Neurol 1998; 40:517-519.
83. SCHAPEL G, CHADWICK D. Tiagabine and non-convulsive status epilepticus. Seizure 1996; 5:153-156.
84. GENTON P. When antiepileptic drugs aggravate epilepsy. Brain Dev 2000; 22:75-80.
85. KNAKE S, HAMER HM, SCHOMBURG U et al. Tiagabine-induced absence status in idiopathic generalized
epilepsy. Seizure 1999; 8:314-317.
86. OSORIO I, REED RC, PELTZER JN. Refractory idiopathic absence status epilepticus: A probable paradoxical
effect of phenytoin and carbamazepine. Epilepsia 2000; 41:887-894.
87. D'AGOSTINO MD, ANDERMANN F, DUBEAU F et al. Exceptionally long absence status: multifactorial
etiology, drug interactions and complications. Epileptic Disord 1999; 1:229-232.